Vor Ort
Merkzettel Warenkorb
  • Produktbild: Incentives for Global Public Health
  • Produktbild: Incentives for Global Public Health

Incentives for Global Public Health Patent Law and Access to Essential Medicines

69,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.09.2013

Herausgeber

Pogge Thomas + weitere

Verlag

Cambridge Academic

Seitenzahl

536

Maße (L/B/H)

22,9/15,2/2,9 cm

Gewicht

710 g

Sprache

Englisch

ISBN

978-1-107-69345-6

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

18.09.2013

Herausgeber

Verlag

Cambridge Academic

Seitenzahl

536

Maße (L/B/H)

22,9/15,2/2,9 cm

Gewicht

710 g

Sprache

Englisch

ISBN

978-1-107-69345-6

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
Die Leseprobe wird geladen.
  • Produktbild: Incentives for Global Public Health
  • Produktbild: Incentives for Global Public Health
  • Introduction: access to essential medicines: public health and international law Thomas Pogge, Matthew Rimmer and Kim Rubenstein; Part I. International Trade: 1. TRIPS and essential medicines: must one size fit all? Making the WTO responsive to the global health crisis Rochelle Cooper Dreyfuss; 2. The TRIPS waiver as a recognition of public health concerns in the WTO Andrew Mitchell and Tania Voon; 3. Public law challenges to the regulation of pharmaceutical patents in the US Bilateral Free Trade Agreements Hitoshi Nasu; 4. Global health and development: patents and public interest Elizabeth Siew Kuan Ng; Part II. Innovation: 5. The Health Impact Fund: boosting innovation without obstructing free access Thomas Pogge; 6. The Health Impact Fund: a critique Kathleen Liddell; 7. A prize system as a partial solution to the health crisis in the developing world William W. Fisher and Talha Syed; 8. Innovation and insufficient evidence: the case for a WTO-WHO agreement on health technology safety and cost-effectiveness evaluation Thomas Faunce; Part III. Intellectual Property: 9. Opening the dam: patent pools, innovation, and access to essential medicines Dianne Nicol and Jane Nielsen; 10. Open source drug discovery: a revolutionary paradigm or a utopian model? Krishna Ravi Srinivas; 11. Accessing and benefit sharing avian influenza viruses through the World Health Organization: a CBD and TRIPS compromise thanks to Indonesia's sovereignty claim? Charles Lawson and Barbara Hocking; 12. The Lazarus effect: the (RED) campaign and creative capitalism Matthew Rimmer; Part IV. Health-Care: 13. Beyond TRIPS: the role of non-state actors and access to essential medicines Noah Benjamin Novogrodsky; 14. Securing health through rights Katharine Young; 15. The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India Rajshree Chandra; 16. Tipping point: Thai compulsory licenses redefine essential medicines debate Jonathan Burton-MacLeod.